Your browser doesn't support javascript.
loading
Nationwide distribution of varicella-zoster virus clades in China.
Xu, Songtao; Chen, Mukai; Zheng, Huanying; Wang, Haiyan; Chen, Meng; Zhou, Jianhui; Shuang, Wang; Yu, Pengbo; Ma, Chaofeng; He, Jilan; Feng, Daxing; Zhen, Zhu; Yan, Zhang; Naiying, Mao; Cui, Aili; Wu, Qiuhua; Qi, Mengyuan; Li, Chongshan; Xu, Xiaoguang; Xu, Wenbo.
Affiliation
  • Xu S; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Chen M; The First Affiliated Hospital of Sun Yat-sen University, Guangzhou City, 510080, Guangdong Province, China.
  • Zheng H; Guangdong Center for Disease Control and Prevention, Guangzhou City, 510300, Guangdong Province, China.
  • Wang H; Shandong Center for Disease Control and Prevention, Jinan City, 250014, Shandong Province, China.
  • Chen M; Beijing Center for Disease Control and Prevention, Beijing City, 100021, China.
  • Zhou J; Jilin province Center for Disease Control and Prevention, Changchun City, 130021, Jilin Province, China.
  • Shuang W; Jilin province Center for Disease Control and Prevention, Changchun City, 130021, Jilin Province, China.
  • Yu P; Shaanxi Center for Disease Control and Prevention, Xian City, 710012, Shannxi Province, China.
  • Ma C; Xi'an city Center for Disease Control and Prevention, Xian City, 710031, Shannxi Province, China.
  • He J; Sichuan Center for Disease Control and Prevention, Chengdu City, 610014, Sichuan Province, China.
  • Feng D; Henan Center for Disease Control and Prevention, Zhengzhou City, 450016, Henan Province, China.
  • Zhen Z; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Yan Z; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Naiying M; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Cui A; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Wu Q; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China.
  • Qi M; Department of Neurosurgery, Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, Liaoning Province, China.
  • Li C; Shanghai Center for Disease Control and Prevention, Shanghai City, 200336, China. 94114911@qq.com.
  • Xu X; Department of Neurosurgery, Second Affiliated Hospital of Dalian Medical University, Dalian, 116027, Liaoning Province, China. xuxg2007@sina.com.
  • Xu W; National Institute for Viral Disease Control and Prevention, China Center for Disease Control and Prevention, Beijing City, 102206, China. wenbo_xu1@aliyun.com.
BMC Infect Dis ; 16(1): 542, 2016 Oct 07.
Article in En | MEDLINE | ID: mdl-27717328
BACKGROUND: In 2010, a universal nomenclature for varicella-zoster virus (VZV) clades was established, which is very useful in the monitoring of viral evolution, recombination, spread and genetic diversity. Currently, information about VZV clades has been disclosed worldwide, however, there are limited data regarding the characterization of circulating VZV clades in China, even where varicella remains widely epidemic. METHODS: From 2008 to 2012, clinical samples with varicella or zoster were collected in General Hospital in eight provinces and analyzed by PCR, restriction endonuclease digestion and sequencing. The viral clades were determined by analysis of five single nucleotide polymorphisms (SNPs) within the 447-bp fragment of open reading frame (ORF) 22, and the restriction fragment length polymorphisms (RFLPs) of ORF 38 (PstI), ORF 54 (BglI) and ORF 62 (SmaI) were evaluated to understand genetic diversity of VZV and determinate varicella vaccine adverse event (VVAE). RESULTS: Seventy-seven varicella and 11 zoster samples were identified as being positive for VZV. The five SNPs profile showed that the majority of VZV strains belonged to clade 2, but clade 5 and clade 4 strains were also found in Guangdong. The RFLPs analysis of the DNA fragments of ORF 38, 54 and 62 showed that 85 of these samples were characterized as PstI + BglI + SamI-, and the remaining three VZV strains from varicella patients were characterized as PstI-BglI + SamI+ which is the genetic profile of VVAEs. CONCLUSIONS: The study suggested that the predominant clade 2 VZVs had been continually circulating since at least the 1950s in China. Nearly all VZV strains except VVAEs possessed the genetic profile of PstI + BglI + Sam-. However, the other clades were also found to be co-circulating with clade 2, especially in the border regions. These results highlighted the need for the constant and broad use of virologic surveillance to provide an important genetic baseline for varicella control and vaccination programs in China.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 3, Human Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2016 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Herpesvirus 3, Human Limits: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Country/Region as subject: Asia Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2016 Document type: Article Affiliation country: China Country of publication: United kingdom